3Braunwald E, Bristow M R. Congestive heart failure:Fifty years of progress. Circulation, 2000, 102:IV14-- IV23.
4Kumar A, Thota V, Dee L, et al. Tumor necrosis factor-α and interleukin-lβ are responsible for in vitro myocardial cell depression induced by human septic shock serum. J Exp Med, 1996, 183: 949--958.
5Yokoyama T, Nakano M, Bendnarczyk J L, et al.Tumor necrosis factor-α provokes a hypertrophic growth response in adult cardiac myocytes. Circulation,1997, 95: 1247--1252.
6Krown K A, Page M T, Nguyen C, et al. Tumor necrosis factor-α induced apoptosis in cardiac myocytes. J Clin Invest, 1996, 98: 2854--2865.
7Aukrust P, Ueland T, Lien E, et al. Cytokines network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol, 1999,83: 376--382.
8Adamopoulos S, Parisis J, Karatzas D, et al. Physical training modulates proinflammatory cytokines and the soluble Fas/souble Fas ligand system in patients with chronic heart failure. J Am Coil Cardiol, 2002,39:653--663.
9Shioi T, Matsumori A, Matoba Y, et al. Inhibition of cytokine production by a new inotropic agent vesnarinone,in human lymphocytes. T cell line, and monocytic cell line. Life Sci, 1994, 54:PL11--16.
10Cohn J N, Goldsrein S D, Greenberg B H, et al. For the Vesnarinone Trail Investigators. A dose-dependent increase in mortality with vesnarinone among patients with severe heart failure. N Engl J Med, 1998, 339:1810--1816.
